These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16604708)

  • 1. Radiopharmaceuticals for targeted radiotherapy.
    Marques F; Paulo A; Campello MP; Lacerda S; Vitor RF; Gano L; Delgado R; Santos I
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):601-4. PubMed ID: 16604708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic and acyclic polyamines as chelators of rhenium-186 and rhenium-188 for therapeutic use.
    Prakash S; Went MJ; Blower PJ
    Nucl Med Biol; 1996 May; 23(4):543-9. PubMed ID: 8832713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auger radiation targeted into DNA: a therapy perspective.
    Buchegger F; Perillo-Adamer F; Dupertuis YM; Delaloye AB
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1352-63. PubMed ID: 16896663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents.
    Gano L; Marques F; Campello MP; Balbina M; Lacerda S; Santos I
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):6-15. PubMed ID: 17372568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
    Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy.
    Ferro-Flores G; Hernández-Oviedo O; Arteaga de Murphy C; Tendilla JI; Monroy-Guzmán F; Pedraza-López M; Aldama-Alvarado K
    Appl Radiat Isot; 2004 Dec; 61(6):1227-33. PubMed ID: 15388114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.
    Liu G; Hnatowich DJ
    Anticancer Agents Med Chem; 2007 May; 7(3):367-77. PubMed ID: 17504162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdosimetric basis of individualized cancer radiotherapy by radionuclides including Auger effect and the photon activation approach.
    Booz J
    Strahlentherapie; 1984 Dec; 160(12):745-54. PubMed ID: 6393457
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and evaluation of intercalating somatostatin receptor binding peptide conjugates for endoradiotherapy.
    Graham K; Wang Q; Garcia Boy R; Eisenhut M; Haberkorn U; Mier W
    J Pharm Pharm Sci; 2007; 10(2):286s-297s. PubMed ID: 17718932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy.
    Uccelli L; Martini P; Pasquali M; Boschi A
    Biomed Res Int; 2017; 2017():5923609. PubMed ID: 28951872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99m)Tc-tricarbonyl complexes functionalized with anthracenyl fragments: synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cells.
    Vitor RF; Esteves T; Marques F; Raposinho P; Paulo A; Rodrigues S; Rueff J; Casimiro S; Costa L; Santos I
    Cancer Biother Radiopharm; 2009 Oct; 24(5):551-63. PubMed ID: 19877885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr).
    Radchenko V; Busse S; Roesch F
    Nucl Med Biol; 2014 Oct; 41(9):721-7. PubMed ID: 25087170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
    Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
    Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA.
    Pereira E; do Quental L; Palma E; Oliveira MC; Mendes F; Raposinho P; Correia I; Lavrado J; Di Maria S; Belchior A; Vaz P; Santos I; Paulo A
    Sci Rep; 2017 Feb; 7():42544. PubMed ID: 28211920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and purification of Scandium-47: A potential radioisotope for cancer theranostics.
    Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M; Asgari M
    Appl Radiat Isot; 2016 Dec; 118():124-130. PubMed ID: 27640172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclisome--targeting the tumor cell nucleus.
    Gedda L; Edwards K
    Tumour Biol; 2012 Jun; 33(3):661-7. PubMed ID: 22302484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.
    Wilbur DS
    Curr Radiopharm; 2011 Jul; 4(3):214-47. PubMed ID: 22201710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.